14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
IBKR vs NMR: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Nomura Holdings, Inc (NMR) captures the overall head-to-head institutional edge over Interactive Brokers Group, Inc. (IBKR) on higher Unified Composite conviction (44.5/100 HOLD vs. 48.5/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, R&D & Supply-Chain Moat), while IBKR wins 4–2 across the 6-pillar growth and valuation breakdown. IBKR trades at $76.40 (23.7x Forward P/E, 77.6% operating margin) versus NMR at $9.34 (12.7x Forward P/E, 25.1% operating margin).
Composite vs. Pillar Nuance: While IBKR currently prints a higher short-term Unified Composite Score (48.5/100 HOLD vs. NMR 44.5/100 HOLD), NMR captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (25.1% vs. 77.6% operating margin) and revenue trajectory (+17.9% vs. +13.5% YoY).
Technical & Structure Timing Caution: IBKR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.7); meanwhile NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IBKR vs NMR. Trailing 12-month operating profitability (IBKR 77.6% vs NMR 25.1%) and valuation multiples (IBKR 23.7x vs NMR 12.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Capital Markets value chain with $139.4B market capitalization and 77.6% operating margin.
OpEx & R&D Reinvestment15.1% of Rev ($4.04B)
90D Engineering Disclosures0 Published
NMR Moat ProfileScale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment52.3% of Rev ($7.77B)
90D Engineering Disclosures0 Published
Investor FAQ IBKR vs NMR Key Questions & Quantitative Answers
As of Nov 17, 2026, Nomura Holdings, Inc (NMR) captures the overall head-to-head institutional edge over Interactive Brokers Group, Inc. (IBKR) on higher Unified Composite conviction (44.5/100 HOLD vs. 48.5/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, R&D & Supply-Chain Moat), while IBKR wins 4–2 across the 6-pillar growth and valuation breakdown. IBKR trades at $76.40 (23.7x Forward P/E, 77.6% operating margin) versus NMR at $9.34 (12.7x Forward P/E, 25.1% operating margin). Composite vs. Pillar Nuance: While IBKR currently prints a higher short-term Unified Composite Score (48.5/100 HOLD vs. NMR 44.5/100 HOLD), NMR captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (25.1% vs. 77.6% operating margin) and revenue trajectory (+17.9% vs. +13.5% YoY). Technical & Structure Timing Caution: IBKR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.7); meanwhile NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
IBKR leads the Growth & Scale pillar: IBKR posts +13.5% YoY revenue growth and +16.9% YoY earnings growth on $26.8B TTM revenue (92.7% gross margin, 77.6% operating margin), compared with NMR at +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin). On trailing 12-month operating scale, IBKR generates $26.8B in USD-normalized revenue versus $14.9B for NMR. In operating R&D and SG&A reinvestment, IBKR deploys 15.1% of Rev ($4.04B) (0 90-day corporate R&D disclosures) versus 52.3% of Rev ($7.77B) (0 disclosures) for NMR.
NMR screens cheaper on headline valuation multiples. IBKR trades at 23.7x Forward P/E, 31.2x Trailing P/E, 1.16x PEG, and 4.4x EV/Revenue (unreported FCF margin), whereas NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IBKR (23.7% ROE) versus NMR (11.5% ROE) capital efficiency.
In options market volatility and institutional positioning, IBKR carries 51.1% implied volatility (54th %ile, Balanced (25th–60th %ile)), a 0.63x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.90β · 52% Vol realized risk). By comparison, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.